Management

Dr. Gulati leads the clinical development and commercialization of first-in-class drug products in critical care medicine. He led the discovery, development, and launch of Lyfaquin for hypovolemic shock and Tyvalzi for cerebral stroke. He has more than 50 issued patents. He is a Professor Emeritus at Midwestern University and the University of Illinois and is the recipient of the Paul R Dawson Biotechnology Award and Littlejohn Award. Dr. Gulati is a United States Fulbright Scholar 2008-2009 and winner of the International Ranbaxy Research Award 2007. Dr. Gulati was the Scientific Reviewer of the United States Defense Medical Research and Development Program, Combat Casualty Care Research Program.

Dr. Neil Marwah is a seasoned, entrepreneurial healthcare executive with more than 30 years of experience. His experience includes private practice, ancillary healthcare services, large provider organizations, government relations, healthcare public policy advocacy, managed care, private equity, and senior management at Global 500 enterprise. As a board-certified nephrologist, Dr. Neil Marwah has strong clinical credentials. He served on the Medical Advisory Board of Banner Health, Arizona’s largest health system; and Fresenius Medical Care, a publicly traded firm with 120,000 employees.

Mr. Costello brings about 20 years of accounting, budgeting, audit preparation, reporting and financial modeling experience to Pharmazz. He served as Controller for Julian Toft and Downey, Inc. and as Vice President in Transwestern Commercial Real Estate’s Capital Markets Group. Mr. Costello has assisted in the closing of over $500 million in structured finance and equity transactions. Mr. Costello has a CPA designation, earning the Elijah Watts Sells Award for passing with honors, and graduated from Western Illinois University in finance, Magna Cum Laude.

Dr. Gulati has more than 38 years of experience and knowledge in starting and running medium sized organizations. He is the founding member of Pharmazz India Private Limited and is managing and operating the company since its inception. He was instrumental in initiating and developing a team to conduct all the clinical trials in-house and is extensively involved in selection of sites, the budgetary aspects and legal contracts. Dr. Gulati has provided his expertise to be in full compliance with all related regulatory affairs pertaining to drug development, customs, licensing, FEMA and others. Dr. Gulati has an exceptional ability to create healthy environment for employees.

Mr. Bajaj is a Certified Public Accountant having more than 30 years of experience in financial planning and analysis. He has performed financial statement audits and SOX internal control review, facilitated external audit review by big ten auditors. He is specialized in financial and accounting systems of the USA and India with emphasis on pharmaceutical sector.

Ms. Shruti Gulati, MS, has over 18 years of combined experience in marketing and regulatory affairs. Her career includes the development and promotion of pharmaceutical products, along with navigating complex regulatory landscapes in global markets. At Pharmazz Inc., she plays a key role in ensuring regulatory compliance, managing regulatory submissions, and supporting strategic initiatives. Her Master’s thesis focused on the neurological aspects of sovateltide.

Dr. Lavhale, Ph.D., has over 25 years of experience in non-clinical and clinical drug development, with a focus on critical care therapeutics. A postdoctoral fellow from Midwestern University, USA, he has led R&D strategy at Pharmazz since its founding in 2011. He has overseen multiple IND submissions in the U.S. and India and played a key role in advancing the company’s pipeline of first-in-class therapies. Dr. Lavhale holds several patents, has published 40+ peer-reviewed articles, and has received research funding from UGC (India) and NIH (USA). His expertise in translational research and regulatory affairs continues to drive innovation at Pharmazz.

Dr. Gulati leads the clinical development and commercialization of first-in-class drug products in critical care medicine. He led the discovery, development, and launch of Lyfaquin for hypovolemic shock and Tyvalzi for cerebral stroke. He has more than 50 issued patents. He is a Professor Emeritus at Midwestern University and the University of Illinois and is the recipient of the Paul R Dawson Biotechnology Award and Littlejohn Award. Dr. Gulati is a United States Fulbright Scholar 2008-2009 and winner of the International Ranbaxy Research Award 2007. Dr. Gulati was the Scientific Reviewer of the United States Defense Medical Research and Development Program, Combat Casualty Care Research Program.

Dr. Gulati has more than 38 years of experience and knowledge in starting and running medium sized organizations. He is the founding member of Pharmazz India Private Limited and is managing and operating the company since its inception. He was instrumental in initiating and developing a team to conduct all the clinical trials in-house and is extensively involved in selection of sites, the budgetary aspects and legal contracts. Dr. Gulati has provided his expertise to be in full compliance with all related regulatory affairs pertaining to drug development, customs, licensing, FEMA and others. Dr. Gulati has an exceptional ability to create healthy environment for employees.

Dr. Dharmesh K. Shah, MBBS, MD, DNB, DM, has conducted many randomized, double-blind phase II and III trials for multinational companies as an investigator. In addition, he has worked as a consultant gastroenterologist at prestigious hospitals and as an assistant professor at Government Medical College, Nagpur. Dr. Shah has taught and guided many fellows in gastroenterology, has several publications in high-impact journals, and has won awards in the national gastroenterology quiz competition.

Mr. Trivedi has over 18 years of experience in analytical Research and Development, with expertise in the development of New Chemical Entities and assisting in the filing of New Drug Applications. At Pharmazz, he leads Research and Development initiatives, manages manufacturing collaborations, and oversees regulatory affairs. His technical expertise, regulatory insight, and leadership play a key role in advancing Pharmazz’s mission to develop breakthrough treatments in critical care medicine.

Mr. Raghav is a seasoned Chartered Accountant with expertise in taxation, financial reporting, and compliance. He has managed complex tax filings and year-end closures across various industries, leading high-performing teams. Raghav adopts a strategic approach to streamline accounting processes, enhance accuracy with ERP systems, and implement standard operating procedures. He is dedicated to meeting statutory obligations while strengthening the company's financial foundation for growth.